Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer.
Watanabe K, Amano Y, Ishikawa R, Sunohara M, Kage H, Ichinose J, Sano A, Nakajima J, Fukayama M, Yatomi Y, Nagase T, Ohishi N, Takai D.
Watanabe K, et al. Among authors: sunohara m.
Cancer Med. 2015 Oct;4(10):1573-82. doi: 10.1002/cam4.505. Epub 2015 Aug 8.
Cancer Med. 2015.
PMID: 26256448
Free PMC article.